FDA INDICATION: Hurler and Hurler-Scheie forms of Mucopolysaccharidosis I (MPS I) and for patients with the Scheie form who have moderate to severe symptoms. Prescribing Information
DISTRIBUTOR: Sanofi Genzyme
ROUTE OF ADMINISTRATION: Intravenous
DOSAGE AND ADMINISTRATION: 0.58 mg/kg of body weight administered once weekly.
HOW SUPPLIED: 5 mL vials, containing 2.9 mg laronidase per 5 mL solution.
DILUENT: 0.9% sodium chloride injection
MAX INFUSION RATE: 200 μg/kg/hr
STORAGE REQUIREMENTS: Refrigerate vials at 2° to 8°C (36° to 46°F). Do not freeze or shake. Protect from light.
OTHER WEBSITES: MPS1Disease.com